Central Admixture Pharmacy Services (CAPS) has expanded its product portfolio, including two vasopressors: norepinephrine 8 mg added to 250 mL normal saline (NS), and vasopressin 50 units added to 50 mL NS. A third product added to the CAPS portfolio is midazolam 125 mg added to NS (1 mg/mL), a CSP used as a sedative. As hospital pharmacies have reported that these key drugs in a ready-to-use format are in short supply for ICU patients, CAPS is responding by adding crucial drugs to its portfolio of 503B compounded products.

CAPS (A B. Braun Company)